News

Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be ...
Quoin Pharmaceuticals Ltd. has filed a U.S. patent application for new topical formulations aimed at treating several skin diseases, specifically Netherton Syndrome (NS) and Peeling Skin Syndrome.
A diagnosis of Netherton syndrome was made and the patient was started on antihistamines, emollients, and 10% urea. In our case, the patient presented at age 17 years. The history of his ...
Video features 79-year-old Norma Coles, believed to be among the earliest individuals ever evaluated for Netherton Syndrome and is available on the company’s NETHERTON NOW website ASHBURN ...
Investing.com — Am Mittwoch hat Citizens JMP seinen positiven Ausblick für BioCryst Pharmaceuticals (NASDAQ: BCRX ), die derzeit bei 7,82 US-Dollar notiert, bekräftigt und wiederholt ein "Market Outpe ...
ASHBURN, VA, April 2, 2025 (EZ Newswire) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late-stage specialty pharmaceutical company focused on rare and orphan ...
Video features 79-year-old Norma Coles, believed to be among the earliest individuals ever evaluated for Netherton Syndrome and is available on the company’s NETHERTON NOW website ASHBURN, Va., April ...